Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-29T14:07:41.909Z Has data issue: false hasContentIssue false

Rhinocerebral mucormycosis: Use of liposomal amphotericin B

Published online by Cambridge University Press:  29 June 2007

Edward W. Fisher*
Affiliation:
London
Abbad Toma
Affiliation:
London
Phillip H. Fisher
Affiliation:
London
Anthony D. Cheesman
Affiliation:
London
*
E. W. Fisher, M.A., F.R.C.S., The Royal National Throat, Nose and Ear Hospital, Gray's Inn Road, London WC1X 8DA.

Abstract

Rhinocerebral mucormycosis is a rare but often fatal condition characterized by an aggressive necrotizing infection spreading from the nose to the paranasal sinuses, orbit and hence to the central nervous system. A case is reported in which a diabetic male with advanced mucormycosis was successfully treated by a combination of surgery, supportive therapy and liposomal amphotericin B. Liposomal delivery allows the drug to be both less toxic and more effective, and this is the first reported case of its use in rhinocerebral mucormycosis.

Type
Clinical Records
Copyright
Copyright © JLO (1984) Limited 1991

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alpar, O. (1989) Liposomes as drug carriers. Pharmaceutical Journal, Aug. 26: 254255.Google Scholar
Bahadur, S., Ghosh, P., Chopra, P., Rai, G. (1983) Rhinocerebral phycomycosis. Journal of Laryngology and Otology, 97: 267270.CrossRefGoogle ScholarPubMed
Baver, H., Ajello, L., Adams, E., Hernandez, D. V. (1955) Cerebral mucormycosis: pathogenesis of the disease. American Journal of Medicine, 18: 822831.Google Scholar
Bergstrom, L., Hemenway, W. G., Barnhart, R. A. (1970) Rhinocerebral and otologic mucormycosis. Annals of Otology, Rhinology and Laryngology, 79: 7181.CrossRefGoogle ScholarPubMed
Blitzer, A., Lawson, W. A., Meyers, B. R., Biller, H. F. (1980) Patient survival factors in paranasal sinus mucormycosis. Laryngoscope, 90: 635648.CrossRefGoogle ScholarPubMed
De Weese, D. S., Schleuning, A. J., Robinson, L. B. (1965) Mucormycosis of the nose and paranasal sinuses. Laryngoscope, 75: 13981407.CrossRefGoogle ScholarPubMed
Estrem, S. A., Tully, R., Davis, W. E. (1990) Rhinocerebral mucormycosis: computed tomographic imaging of cavernous sinus thrombosis. Annals of Otology, Rhinology and Laryngology, 99: 160161.CrossRefGoogle ScholarPubMed
Fong, K. M., Seneviratne, E. M. E., McCormack, J. G. (1990) Mucor cerebral abscess associated with intravenous drug abuse. Australia and New Zealand Journal of Medicine, 20: 7477.CrossRefGoogle ScholarPubMed
Gamba, J. L., Woodruff, W. W., Djang, W. T., Yeates, A. E. (1986) Craniofacial mucormycosis: assessment with CT. Radiology, 160: 207212.CrossRefGoogle ScholarPubMed
Gass, J. D. M. (1961) Acute orbital mucormycosis. Report of two cases. Archives of Ophthalmology, 65: 214220.CrossRefGoogle ScholarPubMed
Hill, H. (1986) Infections. In: Otolaryngology–Head and Neck Surgery (Cummings, C. W., ed.) Vol. 1 (Krause, C. J., ed.) C.V. Mosby: St. Louis, p. 585609.Google Scholar
Lopez-Berestein, G. (1986) Liposomal amphotericin B in the treatment of fungal infections. Annals of Internal Medicine, 105: 13101331.CrossRefGoogle ScholarPubMed
Lopez-Berestein, G. (1987) Liposomes as carriers of antimicrobial agents. Antimicrobial agents and chemotherapy, 31: 675678.CrossRefGoogle ScholarPubMed
Lopez-Berestein, G., Bodley, G. P., Feinstein, V., Keating, M., Frankel, L. S., Zeluff, B., Gentry, L., Mehta, K. (1989) Treatment of systemic fungal infections with liposomal amphotericin B. Archives of Internal Medicine, 149: 25332536.CrossRefGoogle ScholarPubMed
Ostro, M. J., Cullis, P. R. (1989) Use of liposomes as injectable drug delivery systems. American Journal of Hospital Pharmacy, 46: 15761587.Google Scholar
Parfrey, N. A. (1986) Improved diagnosis and prognosis of mucormycosis. A clinicopathological study of 33 cases. Medicine, 65: 113123.CrossRefGoogle ScholarPubMed
Pillsbury, H. C., Newton, D. F. (1977) Rhinocerebral mucormycosis. Archives of Otolaryngology, 103: 600604.CrossRefGoogle ScholarPubMed
Press, G. A., Weindling, S. M., Hesselink, J. R., Ochi, J. W., Harris, J. P. (1988) Rhinocerebral mucormycosis: MR manifestations. Journal of Computer Assisted Tomography, 12: 744749.CrossRefGoogle ScholarPubMed
Price, J. C., Stevens, D. L. (1980) Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis. Laryngoscope, 90: 737747.CrossRefGoogle ScholarPubMed
Rippon, J. W. (1982) Medical Mycology, 2nd edition, W. B. Saunders: Philadelphia, pp. 615640.Google Scholar
Shugar, M. A. (1987) Mycotic infections of the nose and paranasal sinuses. In: Principles and Practice of Rhinology. (Goldman, J. L. ed.) Churchill Livingstone: New York, p. 717734.Google Scholar
Smith, H. W., Kirschner, J. A. (1958) Cerebral mucormycosis. A report of three cases. Archives of Otolaryngology, 68: 715726.CrossRefGoogle ScholarPubMed
Succar, M. B., Nichols, D., Burch, K. H. (1979) Rhinocerebral mucormycosis. Archives of Otolaryngology, 105: 212214.CrossRefGoogle ScholarPubMed
Van derWesthuijzen, A. J., Grotepass, F. W., Wyma, G., Padayachee, A. (1989) A rapidly fatal palatal ulcer: rhinocerebral mucormycosis. Oral Surgery, Oral Medicine and Oral Pathology, 68: 3236.CrossRefGoogle Scholar
Wong, B., Armstrong, D. (1982) Clinical manifestations and management of mucormycosis in the compromised patient. In Fungal Infections in the Compromised Patient. (Warnock, D. W. and Richardson, M. D., eds.) John Wiley: Chichester. pp. 155185.Google Scholar
Yanagisawa, E., Friedman, S., Kundargi, R. S., Smith, H. W. (1977) Rhinocerebral phycomycosis. Laryngoscope, 87: 13191335.Google Scholar
Yousem, D. M., Galetta, S. L., Gusnard, D. S., Goldberg, H. I. (1989) MR findings in rhinocerebral mucormycosis. Journal of Computer Assisted Tomography, 13: 878882.Google Scholar